HI
TARO

Harbour Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Harbour Investments’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$2.12K – 3394
2024
Q1 		$2.12K Hold
50
– – ﹤0.01% 2771
2023
Q4 		$2.09K Hold
50
– – ﹤0.01% 2690
2023
Q3 		$1.89K Hold
50
– – ﹤0.01% 2569
2023
Q2 		$1.9K Hold
50
– – ﹤0.01% 2557
2023
Q1 		$1.22K Hold
50
– – ﹤0.01% 2656
2022
Q4 		$1.45K Hold
50
– – ﹤0.01% 2593
2022
Q3 		$2K Hold
50
– – ﹤0.01% 2507
2022
Q2 		$2K Buy
+50
New +$1.91K ﹤0.01% 2507
2021
Q4 		$3K Hold
50
– – ﹤0.01% 2357
2021
Q3 		$3K Hold
50
– – ﹤0.01% 3244
2021
Q2 		$4K Hold
50
– – ﹤0.01% 3190
2021
Q1 		$4K Buy
+50
New +$3.8K ﹤0.01% 3031

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Harbour Investments's TARO Position: Q2 2024 in Review

Harbour Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 50 shares — an estimated $2.12K sold.

Harbour Investments first reported a position in TARO in Q1 2021 and held it in 12 quarters. The position peaked at $4K in Q2 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Harbour Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Harbour Investments sold 50 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $2.12K.
  • Harbour Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2021 and held it in 12 quarters.
  • Harbour Investments's Taro Pharmaceutical Industries Ltd. position peaked at $4K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Harbour Investments's 13F filing for Q2 2024, filed 26 Jul 2024.